75 related articles for article (PubMed ID: 428905)
21. Comparison of GLP-1 (7-36amide) and GIP on release of somatostatin-like immunoreactivity and insulin from the isolated rat pancreas.
Schmid R; Schusdziarra V; Aulehner R; Weigert N; Classen M
Z Gastroenterol; 1990 Jun; 28(6):280-4. PubMed ID: 2238756
[TBL] [Abstract][Full Text] [Related]
22. Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum.
Hansen L; Hartmann B; Mineo H; Holst JJ
Regul Pept; 2004 Apr; 118(1-2):11-8. PubMed ID: 14759551
[TBL] [Abstract][Full Text] [Related]
23. Glucose, insulin, pancreatic glucagon and glucagon-like immunoreactive materials in the plasma of normal and diabetic children. Effect of the initial insulin treatment.
Matsuyama T; Hoffman WH; Dunbar JC; Foà NL; Foà PP
Horm Metab Res; 1975 Nov; 7(6):452-6. PubMed ID: 1213649
[TBL] [Abstract][Full Text] [Related]
24. Changes in glucagon processing occurring in the intestines of surgically stressed patients.
Tanjoh K; Tomita R; Ishikawa Y; Izumi T; Utagawa S; Kinoshita K
Hepatogastroenterology; 2007; 54(77):1462-6. PubMed ID: 17708277
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of intestinal glucagon-like immunoreactivity (GLI) secretion by somatostatin in man.
Marco J; Hedo JA; Villaneuva ML
J Clin Endocrinol Metab; 1977 Apr; 44(4):695-8. PubMed ID: 849979
[TBL] [Abstract][Full Text] [Related]
26. Identification of glucagon in the gastrointestinal tract.
Sasaki H; Rubalcava B; Baetens D; Blazquez E; Srikant CB; Orci L; Unger RH
J Clin Invest; 1975 Jul; 56(1):135-45. PubMed ID: 237936
[TBL] [Abstract][Full Text] [Related]
27. Specific biologic effects of intestinal glucagon-like materials.
Gutman RA; Fink G; Voyles N; Selawry H; Penhos JC; Lepp A; Recant L
J Clin Invest; 1973 May; 52(5):1165-75. PubMed ID: 4349485
[TBL] [Abstract][Full Text] [Related]
28. Differences in the content of glucagon-like immunoreactivity in rat submaxillary glands.
Paulo E; Keilacker H; Kohnert KD
Exp Clin Endocrinol; 1986 Jun; 87(1):108-11. PubMed ID: 3743642
[TBL] [Abstract][Full Text] [Related]
29. Molecular weight of gut and pancreatic circulating glucagon in the duck.
Krug E; Biehler O; Mialhe P
Horm Metab Res; 1971 Jul; 3(4):258-61. PubMed ID: 5129985
[No Abstract] [Full Text] [Related]
30. Presence of glucagon-(1-21)-Like immunoreactive substance in the dog small intestinal mucosa.
Itoh H; Namba M; Watanabe N; Ohara T; Matsuyama T; Komatsu R; Shinomura Y; Kono N; Tarui S
Biochem Biophys Res Commun; 1989 Dec; 165(3):1010-7. PubMed ID: 2610678
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a heat stable, 12,000 Da, glucagon-like immunoreactive (GLI) peptide from porcine ileum that stimulates hepatic glucose production in vivo and in vitro.
Wider MD
Proc Soc Exp Biol Med; 1985 Jul; 179(3):356-64. PubMed ID: 4001131
[TBL] [Abstract][Full Text] [Related]
32. Glucagon-like immunoreactive peptides in a rat ileal epithelial cell line (IEC-18).
Brubaker PL; Vranic M
Endocr Res; 1987; 13(3):229-41. PubMed ID: 3322805
[TBL] [Abstract][Full Text] [Related]
33. Extraction, gel filtration pattern, and receptor binding of porcine gastrointestinal glucagon-like immunoreactivity.
Holst JJ
Diabetologia; 1977 Apr; 13(2):159-69. PubMed ID: 856653
[TBL] [Abstract][Full Text] [Related]
34. Chromatographic pattern of human intestinal glucagon-like immunoreactivity (GLI).
Valverde I; Villaneuva ML; Lozano I; Román D; Díaz-Fierros M; Marco J
J Clin Endocrinol Metab; 1973 Jan; 36(1):185-7. PubMed ID: 4681882
[No Abstract] [Full Text] [Related]
35. Evidence for the presence of glucagon-like immunoreactivity (GLI) in the pancreas.
Srikant CB; Unger RH
Endocrinology; 1976 Dec; 99(6):1655-8. PubMed ID: 1001259
[TBL] [Abstract][Full Text] [Related]
36. Mouse salivary glands secrete a glucagon-degrading enzyme, not glucagon.
Baldissera FG; Poulsen K; Holst JJ
Endocrinology; 1985 Jul; 117(1):84-7. PubMed ID: 3839183
[TBL] [Abstract][Full Text] [Related]
37. Differential immunoreactivity of plasma glucagon components in man: studies with different glucagon antibodies.
Soybel D; Jaspan J; Polonsky K; Goldberg I; Rayfield E; Tager H
J Clin Endocrinol Metab; 1983 Mar; 56(3):612-8. PubMed ID: 6185527
[TBL] [Abstract][Full Text] [Related]
38. Release of glucagon-like immunoreactive material (GLI) from the isolated perfused jejunum of normal and diabetic rats.
Wójcikowski C; Maier V; Fussgänger R; Pfeiffer EF
Horm Metab Res; 1985 Feb; 17(2):105-6. PubMed ID: 3838731
[No Abstract] [Full Text] [Related]
39. Physicochemical and biological properties of glucagon-like polypeptides from porcine colon.
Conlon JM; Murphy RF; Buchanan KD
Biochim Biophys Acta; 1979 Apr; 577(2):229-40. PubMed ID: 454644
[TBL] [Abstract][Full Text] [Related]
40. Boiling method for the extraction of gut glucagon-like immunoreactive materials.
Tanaka R; Shima K; Tarui S; Nishikawa M
Endocrinol Jpn; 1975 Dec; 22(6):503-7. PubMed ID: 1231992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
